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ABSTRACT 
Amino acids are attractive and promising biochemicals with market capacity 
requirements constantly increasing. Their applicability ranges from animal feed 
additives, flavour enhancers and ingredients in cosmetic to specialty nutrients in 
pharmaceutical and medical fields.  
This review gives an overview of the processes applied for amino acids production and 
points out the main advantages and disadvantages of each.  
Due to the advances made in the genetic engineering techniques, the biotechnological 
processes, and in particular the fermentation with the aid of strains such as 
Corynebacterium glutamicum or Escherichia coli, play a significant role in the 
industrial production of amino acids. Despite the numerous advantages of the 
fermentative amino acids production, the process still needs significant improvements 
leading to increased productivity and reduction of the production costs.  
Although the production processes of amino acids have been extensively investigated in 
previous studies, a comprehensive overview of the developments in bioprocess 
technology has not been reported yet. This review states the importance of the 
fermentation process for industrial amino acids production, underlining the strengths 
and the weaknesses of the process. Moreover, the potential of innovative approaches 
utilizing macro and microalgae or bacteria are presented. 
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1 Introduction 
Amino acids market demand is increasing since the production of monosodium 
glutamate (MSG) started in 1907 (Sano, 2009). Amino acids are used in many industrial 
applications as bulk biochemical to produce a wide range of products such as animal 
feed additives, flavour enhancers in human nutrition or as ingredients in cosmetic and 
medical products.  
Besides the amino acids important role as intermediates as building blocks of proteins, 
they are involved in the regulation of key metabolic pathways and processes that are 
crucial for the growth and the maintenance of organisms (Cesari et al., 2005; Wu, 
2009). In particular, they promote health by several actions, including maximizing the 
efficiency of food utilization, reducing the adiposity, regulating the muscle protein 
metabolism and controlling the growth and immunity of the organism (Yamane et al., 
2007; Wu et al., 2004b; Weinert, 2009). Indeed, it is well documented that an amino 
acids deficiency causes serious diseases both in humans and animals (Paul et al., 2014; 
Wu et al., 2004a). Therefore, the interest in investigating and developing new routes to 
produce them in a more cost-effective and sustainable way has significantly increased in 
the last years. 
Amino acids can be produced by different processes such as extraction from protein 
hydrolysates, chemical synthesis or enzymatic and fermentation pathways with the aid 
of microorganisms. In particular, the fermentation process is becoming one of the most 
promising processes for amino acids commercial production because of the new genetic 
engineering tools applied to maximize yield, specificity and productivity of the target 
compounds (Ikeda, 2003).   
This paper provides an overview of the different processes used for amino acid 
production and underlines the main advantages and disadvantages of each method. 
Moreover, the most common industrially used amino acid producing bacteria 
Corynebacterium glutamicum and Escherichia coli, are presented. Furthermore, process 
parameters, technological issues associated to an industrial amino acid plant and 
possible improvements are also discussed.  
2 Amino acid production  
2.1 Amino acid production: a short history 
The interest in the production of amino acids has increased over the years resulting in 
the development of a variety of technologies. In the 1907, Kikunae Ikeda, at the Tokyo 
Imperial University, started his experiments with the aim of identifying and purifying 
the flavour enhancing principle from the seaweed konbu (Laminaria japonica). After a 
year of research he discovered that the extract consisted of MSG (Kurihara, 2009).  
Soon after his discovery Ajinomoto Co. began extracting MSG from acid-hydrolyzed 
wheat gluten or defatted soybean and selling it as a flavor enhancer (Sano, 2009). 
Kikunae Ikeda is considered the father of MSG as he provided the bases for the amino 
acid production industry. 
The development of new applications for amino acids, such as pharmaceutical, food 
additives, feed supplements, cosmetics, polymer materials and agricultural chemicals, 
led to a fast increase in the amino acid production. Indeed, in 2008 the total amino acids 
market was estimated around USD 5.4 billion (März, 2009) and it is expected to be 
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worth over USD 9.4 billion by 2018 (Transparency Market Research, 2013). However, 
the industrial processes to produce amino acids still need to be optimized. For this 
reason, many companies (Kim 2010) and academic institutions (Kumagai, 2013; Hauer 
et al., 2004) started research in this field with the aim of finding more cost-effective and 
sustainable routes to produce amino acids. 
2.2 Amino acid production processes 
Amino acids are at the present produced through three different routes, namely, 
extraction from protein-hydrolysates, chemical synthesis and microbial processes 
(enzymatic synthesis and fermentation). In Table 1, the different amino acids production 
methods are compared and in Table 2 and Table 3 an overview of the yield obtained 
with the different methods is presented.  
2.2.1 Extraction from protein-hydrolysates 
Extraction from protein-hydrolysates is suitable for large scale industrial production of 
only a few kinds of amino acids such as L-cysteine, L-leucine and L-tyrosine (Ikeda, 
2003). This method exploits the differences in physicochemical properties (such as 
chemical affinity and pH) of the amino acids to separate them (Zhang et al., 2014). 
According to the amino acid of interest different extraction processes can be developed. 
For instance, L-cysteine, traditionally produced from keratin contained in animal and 
human material such as feathers, hair, bristles and hooves, is extracted using activated 
charcoal and concentrated hydrochloric acid (Renneberg,  2008). The main advantage of 
this method relies in the use of industrial by-products or wastes, such as hair, meat 
extracts and plant hydrolysates which are thus exploited for further utilization (Hauer et 
al., 2004). It is a simple method, the reagents that it requires are easily available and the 
technological process is well established. Nevertheless, the high pH conditions could 
lead to protein degradation resulting in a low amino acids yield (Ikeda, 2003). 
Moreover, unwanted reactions, causing molecular rearrangements resulting in formation 
of toxic compounds or in decrease of the nutritive value in the final product, may take 
place. Furthermore, the necessary washing out of the alkali solution from the product 
leads to the generation of large amounts of wastewater (Sereewatthanawut et al., 2008; 
Lütke-Eversloh et al., 2007). 
More effective extraction methods utilizing water at subcritical (100°C < T < 374.2°C) 
or supercritical (T = 374.2 °C and P = 22.05 MPa) conditions have been developed 
(Klejdus et al., 2008; Sereewatthanawut et al., 2008). Sereewatthanawut et al. (2008) 
tested the effect of different temperatures and hydrolyses time in a subcritical water 
process. The results demonstrated that the amino acids yield increases with temperature 
and time. In particular a higher temperature is associated with an increasing in the 
dissociation constant of water (Kw) and thus the concentration of hydronium and 
hydroxide ions increases. Therefore, the presence of these ions breaks down the peptide 
bonds in smaller molecules such as the amino acids. Other examples are L-leucine, L-
alanine and L-serine which are produced from proteinaceous biomass waste material 
derived from animals. These amino acids are extracted in subcritical water, with 
temperatures ranging from 180 to 320 °C and pressures from 3 to 30 MPa. This study 
demonstrated that hydrolyses reaction time and temperature are very important to obtain 
high yield of amino acids. In particular, the maximum yield was obtained at 
temperatures ranging from 200 to 290 °C and reaction time from 5 to 10 min (Cheng et 
al., 2008). 
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Moreover several studies demonstrated that sub- and supercritical methods, utilized to 
decompose organic matter into smaller molecules, are environmentally friendly (Goto et 
al., 2004; Pourali et al., 2008). Indeed, using higher temperatures the dielectric constant 
of water decreases to that of organic compounds. Thus, it is possible to extract organic 
compounds using water instead of organic solvents which are not environmentally 
friendly (Pourali et al., 2008).  
In general, the main bottleneck of these methods is that they are highly dependent on 
the availability of natural protein rich resources so that it may be difficult to satisfy the 
increasing demand of amino acids. 
2.2.2 Chemical synthesis 
Historically, chemical synthesis has been the classical pathway to produce achiral 
amino acids like glycine or a racemic mixture of D, L-methionine or D,L-alanine.  
The first amino acid synthesis was reported in 1850 with the name of Strecker 
synthesis. According to this reaction the conversion of an aldehyde or ketone and amine 
or ammonia to α-amino acids can be achieved by means of an acid catalysts, metal 
cyanide and water (Strecker, 1850). In particular it consists in the reaction of an 
aldehyde with hydrogen cyanide and D-α-methylbenzylamine in methanol, followed by 
the hydrolysis of the resulting amino nitrile to yield the N-α-methylbenzyl amino acid. 
Finally, a catalytic hydrogenolysis is performed to remove the methylbenzyl group from 
the amino acid molecule. Examples of chemical synthesis are the ammonolysis of 
trichloroethylene to glycine (Inoue and Enomoto, 1981) or the ammonolysis of (±)-2-
chloropropionic acid to D,L-alanine (Ogata and Inaishi, 1981). These studies analyzed 
the effect of ammonia molar ratio, reaction time, pressure and temperature on the yield 
of amino acids. Inoue and Enomoto (1981) demonstrated that a higher yield of glycine 
(from 40% to 70% w w
-1
) was obtained after 4 h reaction at a temperature of 180 °C. 
Ogata and Inaishi (1981) obtained a D,L-alanine yield of 78% in 7 h reaction at a 
temperature of 70 °C and ammonia concentration of 22.2 M. However, the main 
drawbacks of the chemical synthesis are associated to the price of the catalyst as well as 
to the use of hazardous cyanide sources (Zuend et al., 2009). Moreover, the Strecker 
synthesis is not enantioselective and therefore it can produce only a mixture of D and L 
forms of amino acids (Gröger, 2003). To overcome these problems new methods, such 
as the catalytic asymmetric Strecker-type reaction introduced in 1963 by Harada et al. 
(1963), using a chiral amino-thiourea catalyst compatible with the safer aqueous 
cyanide salts, have been developed (Zuend et al., 2009). Moreover, these catalysts, 
controlling the hydrocyanation step, are able to selectively increase the synthesis of a 
particular enantiomer.  
The most common industrial chemical process for the manufacture of racemic amino 
acids is the so-called Bucherer-Bergs method which is a variant of the Strecker 
synthesis. According to Bucherer-Bergs method ketones or aldehydes react with 
ammonium carbonate and sodium cyanide to produce hydantoions, followed by 
hydrolysis of the racemic amino acid mixture in a basic medium (Hauer et al., 2004). 
Even if these processes have not yet reached the goal of producing enantiomerically 
pure amino acids, the synthesis of racemic mixtures is of considerable importance 
because they can be further converted readily in target compounds through biochemical 
methods. For instance, to obtain only the desired L-form is required an additional 
optical resolution step, consisting in a chemical or enzymatic procedure where a 
chemical substance or an enzyme such as Aspergillus fumigatus (Singh et al., 2011) can 
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resolve the amino acids. Although the Bucherer-Bergs approach is the most common 
because of its simplicity and effectiveness, the main drawbacks of this method are the 
long reaction times and the elevated temperatures (Heuer et al., 2004). 
2.2.3 Microbial process 
The last route to produce amino acids is through biological processes such as 
enzymatically catalyzed synthesis and fermentation. The enzymatic process is based on 
the action of an enzyme or a combination of them to catalyze the production of the 
desired amino acids. Several enzymes have been used such as hydrolytic enzymes, 
ammonia lyases, NAD
+
-dependent L-amino acid dehydrogenases (Pollegioni et al., 
2003). Most of these enzymes are obtained from microorganisms such as Escherichia 
coli, Saccharomyces cerevisiae, Pseudomonas dacunhae, Crypotococcus lurendii. 
The main advantage of the enzymatic route is that it can produce optically pure D and 
L- amino acids in higher concentrations and with a very low by-products formation 
(Ikeda, 2003). An example of enzymatic extraction of amino acids in small scale 
industries is carried out using dried fish protein and the enzymes Alcalase and Neutrase 
(Ramakrishnan et al., 2013). Ramakrishnan et al. (2013) analysed the effect of reaction 
time on the hydrolysis process. The highest yield of amino acids was obtained with a 
combination of enzymes (Alcalase and Neutrase) and a reaction time of 48 h. On the 
other hand the enzymes are usually expensive and their limited stability is one of the 
main drawbacks of this process (Ikeda, 2003). Therefore, various techniques based on 
immobilized biocatalysts have been developed in order to improve the performance of 
the process. Indeed, Hsiao et al. (1988) demonstrated that using E. coli immobilized by 
polyazetidine the L-phenylalanine yield increases up to 63% (w w
-1
). However this is 
not the best method to produce L-amino acids at industrial scale and it is used only for 
the production of some amino acids such as L-aspartic acid and L-alanine (Zhao et al., 
2014).  
Most of the current industrial processes for amino acids production are based on 
fermentation route. Under aerobic or anaerobic conditions, several microorganisms are 
used to convert the sugars present in a substrate into a broad spectrum of amino acids. 
This process has several advantages compared to the other methods. First of all, it 
produces only the L-form amino acids avoiding further purification steps. Another 
important factor is that it can be operated at mild conditions preventing product 
degradation (Ugimoto, 2010). Furthermore, the maintenance costs are significantly 
lower compared to the extraction processes (Ugimoto, 2010). On the other hand, 
fermentation requires sterility and high energy consumption for oxygen transfer (for the 
aerobic fermentations) and mixing as well as water addition that impact on capital and 
operation costs. Moreover, requirement of bigger reactors, compared to the other amino 
acids production methods, leads to a high capital investment (Ivanov et al., 2014). 
The choice of the best amino acid production method is done analyzing several criteria 
such as available technologies and capital investments, product market size and 
revenues, raw materials and operation costs as well as environmental impact of each 
specific process. However, mainly due to economic and environmental advantages, 
fermentation is the most used process at industrial scale (Ikeda, 2003). 
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3 The fermentation process 
3.1 Amino acid producing bacteria 
The most common bacteria used for amino acid production via fermentation, are C. 
glutamicum and E. coli (Ikeda, 2003). Both can produce a broad spectrum of amino 
acids and several metabolic engineering alterations have been applied to improve their 
performance as amino acid producing organisms.  
Genetically modified C. glutamicum is used to produce lysine or glutamic acid (Becker 
et al., 2011) with high yields (up to 50 % w w
-1
) (Aoki et al., 2005), while E. coli has 
been modified to enable the production of the extremely interesting aromatic amino 
acids such as L-tryptophan, L-phenylalanine and L-tyrosine (Rodriguez et al., 2014a) 
(Table 3). 
3.1.1 Corynebacterium glutamicum 
C. glutamicum is an aerobic non-pathogenic Gram positive soil bacterium, widely used 
in the amino acid production industry and it represents the main amino acids producing 
bacterium. 
C. glutamicum is used for the production of several amino acids such as L-glutamate, L-
lysine, L-phenylalanine (Hermann, 2003), L-threonine (Kumagai, 2000), L-tryptophan 
(Leuchtenberger et al., 2005), L-serine, L-proline, L-glutamine, L-arginine (Utagawa, 
2004) and L-isoleucine. It prefers glucose as carbon source (Eggeling and Bott, 2005), 
but it can utilize also other sugars such as sucrose, fructose, ribose, mannose and 
maltose (Zahoor et al., 2012). Its optimal growth conditions are at a temperature of 
30°C and a pH of 7 (Liebl, 2005). Inhibition studies have been done to determine if 
growth inhibition by substrate and product occurs. It has been demonstrated that with a 
glucose concentration above 50 g L
-1 
and with a L-glutamic acid concentration of 12 g 
L
-1
 the growth decreases (Khan et al., 2005).  
3.1.1.1 Central carbon metabolism of Corynebacterium glutamicum  
The biosynthesis of the amino acids is closely linked to the central metabolism of the 
microorganism. Therefore, being an important microorganism for the amino acid 
production industry, C. glutamicum has been subject of biochemical, physiological and 
genetic studies for several years. Isotopic tracer methods, such as [
13
C]-labelling 
techniques, have been combined with metabolite balancing (Sahm et al., 2000) to 
achieve a better understanding of the central metabolism of C. glutamicum and 
quantifying the in vivo fluxes. 
Three main pathways have been identified: Embden-Meyerhof-Parnas pathway 
(glycolysis), the pentose phosphate pathway (PPP) and the tricarboxylic acid (TCA) 
cycle (Ikeda, 2003) (Yukawa and Inui, 2013). Different enzymes are involved in the 
conversion of carbon between TCA cycle and glycolysis such as 6-phosphogluconate 
dehydrogenase and isocitrate dehydrogenase (Yukawa and Inui, 2013). 
In the glycolysis, responsible of a further catabolism of the sugars, glucose is converted 
into pyruvate and energy carriers such as ATP and NADH (figure 1). 
In the phosphoenolpyruvate (PEP) -pyruvate oxaloacetate node, PEP and pyruvate, end 
products of glycolysis, enter into the TCA cycle (Yukawa and Inui, 2013). 
The TCA cycle (Figure 2), is composed by a catabolic and an anabolic phase. During 
the catabolic phase, the acetyl-CoA, produced by the degradation of sugars, is oxidized 
through several steps in CO2, simultaneously generating NADH (Bott, 2007). During 
the anabolic phase, the TCA cycle produces two precursors of the glutamate and 
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aspartate family of amino acids, 2-oxoglutarate and oxaloacetate, besides other 
intermediates such as succinyl-CoA. 
The PPP is responsible for providing the anabolic reducing power NADPH and ribose 
5-phospate and erythrose 4-phospate, two precursors for the biosynthesis of building 
blocks (Stincone et al., 2015). Moreover, during the cycle, vitamins and cell wall 
constituents essential for the production of amino acids are produced.  
Lysine is produced converting its precursor oxaloacetate to aspartate with the aid of the 
aspB-gene-product (Wittmann and Becker, 2007). Aspartate is then phosphorylated to 
L-4-aspartyl phosphate by the aspartate kinase enzyme (AK), which is in turn converted 
to L-aspartate 4-semialdehyde by the enzyme aspartate-semialdehyde dehydrogenase 
(ASADH). L-aspartate 4-semialdehyde is further converted to dehydrodipicolinate by 
reacting with pyruvate, catalysed by dehydrodipicolinate synthase (DHDPS). L-
piperidine 2,6-dicarboxylate is produced with the aid of the reducing agent NADPH and 
the enzyme dehydrodipicolinate reductase (DHDPR). L-piperidine 2,6-dicarboxylate 
can be directly converted to meso-2,6-diaminopimelate adding an amino-group, process 
called dehydrogenase variant and catalyzed by diamino pimelate dehydrogenase 
(DAPDH) , or by the succinyl variant where several reactions are involved. Finally, the 
meso-2,6-diaminopimelate is decarboxylated to lysine by means of the enzyme 
diaminopimelate decarboxylase (DAPDC). The biosynthetic pathway of L-lysine from 
glucose is shown in Figure 3. 
3.1.1.2 Strain improvement 
The development of innovative techniques in genome analysis enabled a better 
understanding of this microbe (Ikeda and Nakagawa, 2003). Therefore, metabolic 
engineering strategies involving point mutations in genes relevant for the target amino 
acid (Volker, 2006) have been applied in order to maximize its performance such as 
yield, fermentable carbon sources and the products that can be obtained from this 
bacterium.  
Moreover metabolic engineering tools enable the development of more environmentally 
sustainable technologies (Zahoor et al., 2012; Rittmann et al., 2008). Indeed, the 
construction of a recombinant strain allows not only to use a larger range of carbon 
sources including galactose, lactose, xylose or arabinose, but also alternative feedstocks, 
such as glycerol, which can be found in industrial by products, and thereby do not 
compete with food or energy production (Ikeda and Takeno, 2013).  The success of 
these techniques is due to various approaches optimising the entire cellular system 
involving central metabolism, uptake and export systems, energy metabolism, stress 
response and global regulation (Ikeda and Takeno, 2013). 
Previous studies demonstrated that C. glutamicum requires high amounts of NADPH to 
overproduce amino acids such as L-lysine and L-isoleucine (Moritz et al., 2000; 
Bommareddy et al., 2014). Several techniques have been tested to enhance the 
production of NADPH, most of them focused on manipulations to increase the fluxes of 
the PPP, the main producer of this high energy molecule. One of the most innovative 
procedures is the engineering of new enzymes, such as glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), which can produce 2 moles of NADPH from 1 moles of 
glucose (Bommareddy et al., 2014) leading to a higher yield of the target amino acid.  
Moreover, innovative approaches utilizing CRISPR interference (CRISPRi) to modify 
quickly and efficiently the metabolic pathway without gene deletions and mutation has 
been recently developed (Cleto et al., 2016) (see section 3.2.7 for more details). 
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3.1.2 Escherichia coli 
E. coli is an aerobic Gram-negative bacterium commonly found in plants and member 
of the normal intestinal flora in mammals (Gordon, 2013). 
It is a well-known microorganism used to produce several amino acids such as L-
methionine, L-lysine and L-threonine (Ikeda and Takeno, 2013) and the aromatic amino 
acids, L-phenylalanine, L-tyrosine and L-tryptophan. Moreover, metabolic engineering 
techniques by means of site-specific mutagenesis, transcriptional attenuation regulations 
and modification of the pathway by depletion of specific genes, enable the creation of a 
mutant strain of E. coli, able to produce the branched chain amino acids L-valine, L-
leucine and L-isoleucine which are extremely interesting for their potential as feed 
additives, cosmetics and pharmaceuticals (Park and Lee, 2010). 
The main substrates that E. coli is able to ferment are glucose, sucrose, mannose, 
xylose, arabinose, galactose and fructose (Sabri et al., 2013; Desai and Rao, 2010; 
Ikeda, 2003). The optimum growth conditions are at a temperature of 37°C and a pH of 
7 (Noor et al., 2013). 
3.1.2.1 Central carbon metabolism of Escherichia coli 
E.coli central carbon metabolism consists of three main pathways such as Embden-
Meyerhof-Parnas pathway (glycolysis), the PPP and the TCA cycle. In particular, the 
PPP is responsible for the breakdown of the carbon sources that E. coli utilizes for the 
biosynthesis of amino acids. Moreover, the PPP generates the reducing power NADPH 
necessary to their synthesis (Figure 4). In E. coli the PPP occurs in two phases: 
oxidative and non-oxidative. During the oxidative phase of the cycle CO2 together with 
intermediate five carbon sugar ribulose-5-phospate are produced. While during the non-
oxidative phase the D-ribulose-5-phospate is converted into D-fructose-6-phosphate and 
D-glyceraldehyde-3-phosphate (Sprenger, 1995). In the first step of the oxidative 
branch, glucose is phosphorylated to glucose-6-phosphate by means of the hexokinase 
enzyme. Glucose 6-phosphate dehydrogenase (G6PD) catalyzed the dehydrogenation of 
glucose-6-phosphate to 6-phospho-D-glucono-1,5-lactone with the production of 
NADPH. G6PD has been intensively studied in recent years for being a branching point 
in the PPP and for being essential in the formation of NADPH (Sprenger, 1995). The 
regulation of this enzyme is strictly correlated to the carbon source used to grow E. coli. 
Previous studies demonstrated that cells grown on glucose has a cellular growth rate 
fourfold higher that cells grown on acetate (Sprenger, 1995). The following step in the 
PPP is the hydration of 6-phospho-D-glucono-1,5-lactone to 6-phospho-D-gluconate by 
means of 6-phosphogluconolactonase (PGLS) and finally 6-phospho-D-gluconate is 
converted to D-ribulose-5-phosphate through an oxidative decarboxylation reaction 
catalyzed by 6-phosphogluconate dehydrogenase (6PGD). In the non oxidative branch, 
through several steps catalyzed by transketolase enzyme (TKT), D-ribulose-5-phosphate 
is converted to D-glyceraldehyde-3-phosphate and D-fructose-6-phosphate. 
 
3.1.2.2 Strain improvement 
E. coli has been genetically modified in order to expand the range of substrates that can 
be utilized and enhance the productivity of different and important amino acids, 
particularly branched amino acids such as L-isoleucine (Park et al., 2012). Furthermore, 
developments in bioprocess engineering and biology concerning the generation, 
characterization and optimization of E.coli, have led to an improvement in the 
production of aromatic amino acids (AAA) such as L-tryptophan, L-phenylalanine and 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 10 
L-tyrosine produced through the shikimate pathway (Rodriguez et al., 2014). In this 
pathway (Figure 5) the PEP and the D-erythrose-4-phosphate, produced through the 
central carbon pathway, are combined to form 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP) and then converted to chorismate, the precursor in the AAA 
synthesis (Rodriguez et al., 2014) (Koma et al., 2012). In particular, to increase the 
production of AAA, techniques aiming at increasing the availability of precursors such 
as PEP and erythrose-4-phosphate, enhancing the carbon flow through the pathway 
(Bongaerts et al., 2001) and identifying the rate-limiting enzymatic reactions have been 
applied (Koma et al., 2012). Modifications such as overexpression of transketolase 
(tktA) and PEP synthase (pps) genes, deletion of PEP carboxylase gene (ppc) 
(Yakandawa et al., 2008), overexpression or deletion of carbon storage regulator genes 
(csrA or csrB) (Tatarko and Romeo, 2001) and glucose transport system exchange have 
been used (Yi et al., 2003). In the production of L-phenylalanine the enzymes involved 
in the most important steps of the shikimate pathway, DAHP synthase (aroG) and 
chorismate mutase/prephenate dehydrase (pheA), are inhibited by the L-phenylalanine 
production. These enzymes are controlled by the transcriptional repressor tyrR. 
Therefore, the deletion of tyrR leaded to a higher L-phenylalanine production (Pittard et 
al., 2005).   
3.2 Process design in amino acid production 
3.2.1 Process monitoring 
In a fermentation process, constant monitoring of crucial parameters and process 
variables such as quality of inoculum, pH, feed rate, aeration intensity and process 
temperature is required (Scheper and Lammers, 1994). 
Moreover, the inoculum preparation is a key step in a bioprocess since it could 
significantly influence the productivity and yield (Ikeda, 2003; Hermann, 2003). 
Therefore to ensure the optimal state for inoculation, inoculum stability and 
productivity should be thoroughly tested before being transferred to the main fermentor. 
Furthermore, to avoid contaminations, sterility has to be maintained throughout the 
process. Thus continuous sterilization systems have been integrated in the classical 
fermentor configuration to ensure aseptic condition during all the stages of the process 
(Junker et al., 2006).  
It has been demonstrated that according to the biochemical characteristics of the amino 
acids the oxygen transfer rate (OTR) influences the productivity (Villadsen et al., 2011). 
Indeed it has been shown that an increment in the OTR has led to a 45% higher L-
phenylalanine productivity and yield (Shu and Liao, 2002) while the L-tryptophan 
production was favored by lower oxygen transfer conditions since the carbon flow 
towards the aromatic amino acid pathway increases (Kocabaş et al., 2006).  
Also the process temperature has to be carefully chosen taking into consideration the 
target compound to be produced. Indeed in some studies on C. glutamicum a high 
temperature (up to 41 °C) has been used to increase the productivity of some amino 
acids such as L-glutamic acid (Delaunay et al., 2002). Furthermore thermotolerant 
bacteria, such as Bacillus methanolicus, that can produce L-lysine and L-glutamate at 
temperatures up to 50 °C, are being investigated (Brautaset et al., 2007). Indeed a higher 
growth temperature represents an advantage with respect to the lower amount of cooling 
water required for the reactor (Hermann, 2003).  
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3.2.2 Fed-batch production 
The most common reactor operation mode used in the amino acid industry is the fed-
batch operation (Ikeda, 2003). In this configuration the process is started with only a 
small amount of medium and inoculum. The carbon source is fed in the reactor 
following a pre-defined feed profile developed to obtain higher yield or productivity. 
During this procedure no effluent is withdrawn and both cell and products remain in the 
reactor. The nutrients necessary to perform the fermentation, such as ammonium sulfate 
or pure ammonia, biotin and other vitamins, are supplied at the beginning with the 
inoculum (Hermann, 2003). This configuration ensures an adequate oxygen capacity to 
satisfy the oxygen demand, preventing oxygen limitation in the culture with consequent 
formation of undesired by-products (Hermann, 2003). Thereby a better control of the 
nutrient concentration and therefore an increased productivity and yield are achieved 
(Hermann, 2003). In particular, in the study of Abou-taleb (Abou-taleb, 2013) the 
performance of Bacillus sp. in a batch and fed-batch configuration were compared. 
They demonstrated that the fed-batch process outcompeted the batch with a total amino 
acids concentration of 4.5 g L
-1
 and 2.8 g L
-1
, respectively. Despite its simplicity in 
terms of process control and technology, the batch configuration has a lower 
productivity and reproducibility compared to the fed-batch procedure (Longobardi, 
1994). The important rationale of fed batch operations are not only the aforementioned 
increased process performance, but also the increased process reproducibility and the 
reduced inhibition risk due to the high carbon content at the beginning of the 
fermentation (Gnoth et al., 2007). 
3.2.3 Continuous production 
This operation mode can provide productivity and process outputs 2.5 fold higher than 
the fed-batch technology (Ikeda, 2003). However, the main drawbacks of this 
configuration process are the increased contamination risk, due to the continuous flows 
into and from the reactor, and the possible strain instabilities caused by the continuous 
changes in the working conditions (Hermann, 2003). Previous studies demonstrated the 
potential of the continuous processes. In particular, Koyoma et al. showed that the 
productivity of L-glutamic acid achieved by means of Brevibacterium lactofermentum 
in a continuous configuration, doubled the one achieved with the batch process, 
reaching 8 g L
-1
 h
-1 
(Koyoma et al., 1998).  
Moreover, to improve the performance of the continuous configuration, a cascade 
bioprocess may be applied. According to this methodology the microorganisms’ growth 
phase can be done in a separated reactor than the production process itself, allowing 
optimized conditions in both the phases. Moreover, higher growth rates allow lower 
residence time with consequent smaller bioreactors and higher productivities (Hermann, 
2003).       
3.2.4 Downstream separation and purification 
An efficient downstream and purification process is crucial to reduce the costs related to 
the amino acids production (Hermann, 2003). The separation of the amino acids from 
the fermentation broth is usually done by centrifugation or filtration followed by a 
purification step using chromatographic techniques chosen according to the product 
properties such as solubility, isoelectric point and affinity to adsorbent (Hermann, 
2003). However, a significant loss of products, due to the numerous removal steps 
required in the purification phase, and the high costs associated to the production of 
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high purity amino acids, represent the main disadvantages of the process (Hermann, 
2003; Kumar et al., 2014). Therefore, membrane-based processes, because of their high 
selectivity combined with low demand of heat inputs, are gaining increasing interest 
(Kumar et al., 2014). The most common membrane-based process to separate target 
amino acids is ion exchange chromatography (Kumar et al., 2014). Furthermore, new 
techniques have being investigated in order to increase the processes performance and 
hence raise the revenues. Nanofiltration is an innovative technique among the pressure 
driven membrane filtration methods (Mänttäri et al., 2013, Ecker et al., 2012). These 
membranes can be easily integrated with the conventional fermentors combining 
production and purification in the same operation unit and therefore reducing the capital 
investment (Kumar et al., 2014). 
3.2.5 Process modelling and analysis 
Another key factor in the amino acid fermentation industry is the fermentor scale-up 
(Takors, 2012). In a larger scale reactor, the different geometry and physical conditions 
may affect important parameters leading to a lower process stability, reproducibility and 
yields and to the formation of unwanted by-products that may affect the final product 
quality (Takors, 2012). In particular, industrial bioprocesses are often affected by lower 
mixing efficiency with consequent long mixing times that, combined with the high 
metabolic activity of microbial cells, results in the formation of local gradients into the 
bioreactors (Lara et al., 2006). Moreover, this problem is compounded by the increased 
reactor size. According to the conventional fermentor design, the substrate is supplied 
from the top, while the aeration from the bottom. The concentration gradients of 
substrate and oxygen follow an opposite trend along the reactor height. In an industrial 
fermentor these gradients are more pronounced due to a longer distance to be covered, 
leading to larger substrate and oxygen depletion zones, larger volumes of culture broth 
to be stirred thereby longer mixing time as well as stronger hydraulic pressure gradient 
influencing the oxygen transfer rate (Lara et al., 2006). Therefore, the microorganisms 
at the top of the fermentor are simultaneously exposed to a high sugar concentration 
together with oxygen limitations, while the one at the bottom are exposed to glucose 
restrictions (Schmidt, 2005).Therefore, as a consequence of the combined high glucose 
concentration and oxygen limitation in the reactor, acetate, ethanol, lactate, hydrogen, 
succinate and formate are produced in high amounts (Castan and Enfors, 2001). 
These acid products lead to an acidification of the medium that, together with the 
excessive heat generated by the agitation, induce the formation of zones with stress 
conditions where the microorganisms cannot perform well (Bylund et al., 1998). 
To investigate the impact of these parameters on an industrial process several 
techniques such as computational fluid dynamics (CFD) and scale down approaches 
have been applied.  
3.2.5.1 Scale down approach 
Scale down devices are gaining increasing attention as tools for imitating the large scale 
bio-reactors conditions and thereby to predict reductions of yield and productivity 
(Takors, 2012). Two-stirred tank reactors or a stirred tank followed by a plug flow are 
the most common configurations (Takors, 2012). Such devices are used to generate 
oscillating supply conditions within laboratory bioprocesses, enabling the selection of a 
robust strain and enhancing the transferability of the process from small to a bigger 
scale (Neubauer and Junne, 2010). However, in order to have an appropriate prediction 
model of the large scale reactor performance, the scale down design has to be tailored to 
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the corresponding conditions of the industrial process (Delvigne et al., 2006). The 
potential of the scale-down approach is underlined in several publications such as in the 
work of Enfors et al. (Enfors et al., 2001) where comparison among a big scale, a lab 
scale and a scale-down reactor using E. coli is presented. Moreover, in Käß et al. (Käß 
et al., 2014), as well as in Lemoine at al. (Lemoine et al., 2015), the effect of the process 
inhomogeneity and oscillatory conditions on C. glutamicum have been investigated.  
3.2.5.2 Computational Fluid Dynamics (CFD) 
Process modelling can support the design and the optimization of all these processes. 
Models, considering the process operative parameters, process stoichiometry and the 
environmental aspects (Elmar et al., 2007), give an estimation of the process efficiency, 
the product titer, selectivity as well as the condition for an optimal yield. Moreover, 
CFD methods can be performed to get a mathematical abstraction of the mixing 
behavior. Based on the Reynolds averaged Navier-Stokes equations and the Eulerian-
Eulerian two phase approach, CFD methods simulate the turbulent flow behavior of an 
industrial-size reactor (Campolo et al., 2002). The final results provide detailed 
information regarding the fluid velocity, the temperatures as well as the concentration 
profile throughout the reactor. 
Such approach can help in the optimization of existing processes but above all it 
represents a useful support to develop new plants. Combining the results obtained by 
the models with the data obtained by the scale down devices, the optimal process 
configuration can be identified in an early phase of development.  
Therefore, although several studies have been done in the computational field, better 
simulators are needed to further support scale-up. 
3.2.6 Process integration opportunities: process intensification 
Another important tool to enhance the productivity of an amino acid fermentation 
process is the process intensification (PI). PI is defined as any technological 
development that lead to a safer, cleaner and more energy efficient process (Babi et al., 
2016). In this field two different approaches can be followed: intensification of the 
equipment such as new reactors, heat exchangers or mass transfer units, or 
intensification of the process itself using innovative separations strategies or techniques 
(Vaghari et al., 2015). For example, changing the reactor configuration (operation 
mode) to repeated batch or fed-batch reactors, may lead to a lysine productivity that is 
twice that of the batch (Ikeda, 2003). According to this configuration, after the first 
batch or fed-batch operation, a portion of 60% and 90% of the final broth is transferred 
to the downstream while the other part remains in the vessel (Hermann, 2003). The 
reactor is then refilled with fresh medium to its starting working volume and the next 
fermentation starts regularly. Reducing the time needed to introduce new inoculum in 
the system and the down time to prepare the sterile bioreactor, a shorter fermentation 
time, with a higher productivity and a significant improvement in the process economics 
can be obtained (Ikeda, 2003).    
Moreover, membranes are good examples of innovative separation strategies; they 
enable to improve the performance of processes and to achieve a more efficient 
transport of specific compounds (Drioli et al., 2011). Recently, electro-membrane 
filtration was applied for the separation of amino acids (Kattan Readi et al., 2014). In 
particular, Kumar et al. demonstrated that electro-membranes enable the separation of 
L-glutamic acid and L-lysine, because of the opposite charge of the two amino acids 
due to their different isoelectric point. Combining the effect of the iso-electric 
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separation with the membrane selectivity a L-glutamic acid recovery of 85% was 
achieved, demonstrating the great potential of these techniques for industrial 
applications (Kumar et al., 2010). This approach integrates the reaction with the 
separation of the biomolecules in the same operation units leading to the possibility for 
process intensification (Kattan Readi et al., 2014).  
3.2.7 Novel approaches 
In the past, most of the microorganisms were modified by random mutagenesis. 
However, the random distribution of mutations can cause unwanted modifications, 
growth defects and genetically unstable microorganisms. The development of omics 
technologies combined with computational analyses, enabled to target specific genes, 
knocking out or introducing them into the microorganisms, with a consequent rational 
metabolic engineering of the bacterial strains (Chen et al., 2013). New technologies 
using advanced synthetic biology and metabolic engineering techniques have been 
applied to increase the microbial cells productivity (Hirasawa and Shimizu, 2016; Zhou 
and Zeng, 2015a). Park et al. (2007) demonstrated that a rational engineering of E. coli 
increased the production of L-valine up to 0.378 g of L-valine per g of glucose. In their 
study metabolic engineering strategies involving the removal of feedback inhibition and 
transcriptional attenuation by site-direct mutagenesis have been successfully 
implemented. Transcriptional attenuation sites were removed by homologous 
recombination with the tac promoter. Feedback inhibition in AHAS III was removed by 
substitution of the 41
st
 base G with A and of the 50
th
 base C with T. Moreover, the 
carbon flux toward L-valine synthesis was increased knocking out the ilvA gene 
responsible for encoding L-threonine dehydratase. The engineered strain was able to 
produce 60.7 g of L-valine per L without by-product formation.   
Furthermore, since the central genes for metabolism directly impact the production of 
amino acids, techniques such as riboswitch and CRISPRi enable the construction of 
optimized microorganisms, improving the production of amino acids and other high 
value chemicals (Zhou and Zeng, 2015b; Wendisch et al., 2016). CRISPRi interference 
technology with the deactivated Cas9 protein (dCas9) was used by Cleto et al. (2016) to 
determine the effect of target gene repression on L-lysine and the L-glutamate 
production. In their study they demonstrated that the application of CRISPRi/dCas9-
mediated for pathway engineering in C. glutamicum strongly enhanced L-lysine and the 
L-glutamate production. pgi, pck, and pyk genes, coding for enzymes involved in the 
production of these two amino acids, were selected as targets for repression using 
sgRNA/dCas9. They proved that the deletion of pgi leads to an overproduction of 
NADPH though the pentose phosphate pathway with a consequent higher L-lysine 
yield. Moreover, the deletion of pck and pyk genes, results in an accumulation of L-
glutamate through an enhanced flux of oxaloacetate in the TCA cycle, due to the 
absence of the transformation of oxaloacetate to phospoenolpyruvate. They 
demonstrated that final L-lysine and L-glutamate yields obtained with the reduced 
expression of pgi, pck, and pyk genes are comparable to the one obtained by gene 
deletion  (Cleto et al., 2016). 
Therefore CRISPRi represents a quick and efficient solution to modify the pathway 
without complex gene deletions or mutations (Dominguez et al., 2016).   
Moreover, innovative approaches to increase the amino acids content by means of a 
protein up-concentration technique have recently been developed. The approach 
consists of extracting the carbohydrate fraction through enzymatic hydrolysis (EH) -to 
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produce fermentable sugars – and obtaining a residue rich in proteins. This approach 
was demonstrated by Alvarado-Morales et al. (2015). Alvarado-Morales et al. (2015) 
used macroalgae Laminaria digitata as a substrate, which mainly consists of 
carbohydrates and to a lesser extent proteins. As a first step EH was performed to 
convert the carbohydrate fraction in fermentable sugars (mainly glucose and mannitol). 
Then, the liquid hydrolysate was separated from the solid leftover by centrifugation and 
the proteins were quantified. The leftover residue after EH had a protein content 3.5 
fold higher than the original substrate. Moreover, the proteins bioavailability and 
digestibility, after the removal of the cell wall polysaccharides, are increased, resulting 
in a higher nutritional value of the protein (Fleurence, 1999).  
With this approach a final product rich in proteins with potential applications as 
bioactive compound in food or feed as well as in pharmaceutics can be produced 
without targeting a particular amino acid.  
A different methodology to produce proteins is represented by the growth of cells of 
microorganisms suitable for the production of single cell proteins (SCP) (Suman et al., 
2015). Numerous microbes, such as algae, fungi, yeast and bacteria (methylotrophs and 
hydrogen-oxidizing bacteria) and a variety of inexpensive substrates and wastes are 
suitable for the production of SCP (Nasseri et al., 2011). Moreover these 
microorganisms are able to accumulate extremely high amounts of other compounds 
such as fats, carbohydrates, nucleic acids, vitamins and minerals. Furthermore they are 
rich in essential amino acids.  These features make them excellent candidates to produce 
protein supplements in human or food nutrition. Recently an innovative approach that 
combines the growth of bacteria with the conversion of nitrogen and carbon dioxide 
recovered from wastewater streams have been proposed (Matassa et al., 2016). 
Therefore, autotrophic hydrogen-oxidizing bacteria (HOB), capable of oxidizing 
hydrogen and fixing carbon dioxide into cells, have been studied. Moreover, the final 
HOB composition is characterized by all the essential amino acids, enabling their 
utilization as high quality protein source for human and animal nutrition (Matassa et al., 
2016).  
Another novel approach to enhance the protein content in the final product is the 
utilization of macrophytes such as microalgae. These unicellular species are able to 
accumulate proteins to a large extent, achieving a composition ranging from 40% to 
70% of the dry weight (Gatenby et al., 2003; Becker, 2007; Costard et al., 2012). The 
use of microalgae can offer several advantages. They can grow very rapidly, with a 
doubling time of few hours, in a wide range of aquatic environments including 
freshwater, biomass hydrolysates (Xu et al., 2006) as well as wastewaters (Ramos 
Tercero et al., 2014). Moreover microalgae can utilize the residual sugars presented in 
industrial waste-streams (Bumbak et al., 2011).  
To demonstrate their versatility Chlorella protothekoides was grown heterotropically 
utilizing the sugars presented in the hydrolysate macroalga L. digitata (D’Este et al., 
2017). In this study L. digitata, a common macroalgae species in Danish waters, rich in 
sugars, has been used as substrate and nutrient source in heterotrophic microalgae 
cultivation. Sugars and nutrients from macroalgae are recovered by enzymatic 
hydrolyses and used to grow C. protothekoides to be used directly as fish feed. This 
work demonstrates that the protein content in the microalgae increased from 0.1 
gProtein gDryMatter
-1
 to 0.4 gProtein gDryMatter
-1
.  
Therefore, the microalgae ability to easily adapt their metabolism to the environmental 
conditions such as temperature (Renaud et al., 2002), pH, O2 or CO2 supply, salts 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 16 
(Garcia et al., 2012), nutrients, light or dark growth conditions (Graziani et al., 2013) 
changing their final chemical composition, enables to modify, control and optimize the 
formation of target compounds. Due to these reasons microalgae are an important 
source of amino acids representing an innovative trend for a future prospective (Kim, 
2013).  
 
4 Conclusions 
 
This review analyzed the three processes applied in the manufacture of amino acids, 
namely, extraction from protein-hydrolysates, chemical synthesis and microbial 
methods, underlying the advantages and the drawbacks of these methods. 
Due to economic and environmental advantages as well as to the development of new 
genetic engineering techniques, the fermentation is the most used process at industrial 
scale. Therefore, several studies involving mutagenesis and metabolic engineering 
approaches have been applied aiming to improve amino acid producing strains and 
thereby enhance amino acids productivity and expand the spectrum of products and 
feedstocks for fermentation. Owing to these technologies we are now able to produce 
amino acids using also residues and waste streams as feedstocks that do not compete 
with human food. Moreover, optimization of the downstream processing is crucial to 
reduce the production cost. The creation of microbial strains with improved amino acid 
productivity and lower by-product formation is essential to reduce the purification costs. 
Innovative separation techniques, such as the nanofiltration membranes, can be 
integrated in the classical fermenters combining production and purification in the same 
unit according to the principles of the process intensification. Furthermore, techniques 
able to mimic the behavior of bigger scale reactors such as computation fluid dynamics 
or the scale down devices can reduce the issues deriving from the scale-up of industrial 
bioreactors. Therefore, a combination of process modeling, simulations and metabolic 
engineering tools can lead to the development of the optimal process configuration in an 
early phase of the process design, thereby minimizing uncertainties in the process 
performance.  
The potential of innovative approaches utilizing macro- and microalgae or bacteria was 
also presented. These approaches enable the conversion of a variety of inexpensive 
substrates and wastes into high quality proteins rich in essential amino acids. These 
features make them excellent candidates to produce protein supplements in human or 
food nutrition representing an innovative trend for the future. 
 
Acknowledgement 
This work was supported by the Danish Council for Strategic Research via the 
MacroAlgaeBiorefinery (MAB3) project.  
 
Conflict of interest 
The authors declare no financial or commercial conflict of interest. 
 
 
References 
Abou-taleb, K., 2015. Enhancing production of amino acids from Bacillus spp. using 
batch and fed-batch fermentation strategies. Br. Microbiol. Res. J.5: 257-272. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 17 
Alvarado-Morales, M., Gunnarsson, I.B., Fotidis, I. A., Vasilakou, E., Lyberatos, G., 
Angelidaki I., 2015. Laminaria digitata as a potential carbon source for succinic acid 
and bioenergy production in a biorefinery perspective. Algal Res. 9:126–132. 
Aoki, R., Wada, M., Takesue, N., Tanaka, K., Yokota, A., 2005. Enhanced glutamic 
acid production by a H+-ATPase-defective mutant of Corynebacterium glutamicum. 
Biosci. Biotechnol. Biochem. 69(2247):1466–1472.  
Babi, D. K., Cruz, M. S., Gani, R., 2016. Fundamentals of Process Intensificatoin: A 
Process Systems Engineering View, in Sergovia-Hernández, J. G., Bonilla-Petriciolet, 
A. (Eds.), Process Intensificatoin in Chemical Engineering, Springer. 
Becker, E.W., 2007. Micro-algae as a source of protein. Biotechnol. Adv. 25(2):207–10.  
Becker, J., Zelder, O., Häfner, S., Schröder, H., Wittmann, C., 2011. From zero to hero-
Design-based systems metabolic engineering of Corynebacterium glutamicum for L-
lysine production. Metab. Eng. 13:159–68.  
Bommareddy, R.R., Chen, Z., Rappert, S., Zeng, A.P., 2014. A de novo NADPH 
generation pathway for improving lysine production of Corynebacterium glutamicum 
by rational design of the coenzyme specificity of glyceraldehyde 3-phosphate 
dehydrogenase. Metab. Eng. 25:30–7.  
Bongaerts J., Krämer M., Müller U., Raeven L., Wubbolts M., 2001. Metabolic 
engineering for microbial production of aromatic amino acids and derived 
compounds. Metab. Eng. 3: 289–300. 
Bott, M., 2007. Offering surprises: TCA cycle regulation in Corynebacterium 
glutamicum. Trends Microbiol. 15, 417–425. doi:10.1016/j.tim.2007.08.004 
Brautaset, T., Jakobsen, Ø.M., Josefsen, K.D., Flickinger, M.C., Ellingsen T.E.,  2007. 
Bacillus methanolicus: A candidate for industrial production of amino acids from 
methanol at 50°C. Appl. Microbiol. Biotechnol. 74:22–34.  
Bumbak, F., Cook, S., Zachleder, V., Hauser, S., Kovar, K., 2011. Best practices in 
heterotrophic high-cell-density microalgal processes: Achievements, potential and 
possible limitations. Appl. Microbiol. Biotechnol. 91(1):31–46.  
Bylund, F., Collet, E., Enfors, S. O., Larsson, G., 1998. Substrate gradient formation in 
the large-scale bioreactor lowers cell yield and increases by-product formation. 
Bioprocess Eng. 18: 171-180. 
Campolo, M., Paglianti, A., Soldati, A., 2002. Fluid Dynamic Efficiency and Scale-up 
of a Retreated Blade Impeller CSTR. Ind. Eng. Chem. Res. 41:164–172.  
Castan, A., Enfors, S.O., 2001. Formate accumulation due to DNA release in aerobic 
cultivations of Escherichia coli. Biotechnol. Bioeng. 77:324–328.  
Cesari, M., Rossi, G.P., Sticchi, D., Pessina, A.C., 2005. Is homocysteine important as 
risk factor for coronary heart disease? Nutr. Metab. Cardiovasc. Dis. 15(2):140–147. 
Chen X., Zhou L., Tian K., Kumar A., Singh S., Prior B. A., Wang Z., 2013. Metabolic 
engineering of Escherichia coli: a sustainable industrial platform for bio-based chemical 
production. Biotechnol. Adv. 31: 1200-1223 
Cheng, H., Zhu, X., Zhu, C., Qian, J., Zhu, N., Zhao, L., Chen, J., 2008. Hydrolysis 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 18 
technology of biomass waste to produce amino acids in sub-critical water. Bioresour. 
Technol. 99: 3337-3341. 
Cleto, S., Jensen, J.V., Wendisch, V.F., Lu, T.K. 2016. Corynebacterium glutamicum 
metabolic engineering with CRISPR interference (CRISPRi). ACS Synth. Biol. 5:375-
385.  
Costard, G.S., Machado, R.R., Barbarino, E., Martino, R.C., Lourenco, S.O., 2012. 
Chemical composition of five marine microalgae that occur on the Brazilian coast. Int. 
J. Fish. Aquacult. 4(9):191–201.  
D’Este, M., Alvarado-Morales, M. , Angelidaki, I., 2017. Laminaria digitata as 
potential carbon source in heterotrophic microalgae cultivation for the production of 
fish feed supplement. Algal Res. 26: 1-7. 
Delaunay, S., Lapujade, P., Engasser, J.M., Goergen, J.L., 2002. Flexibility of the 
metabolism of Corynebacterium glutamicum 2262, a glutamic acid-producing 
bacterium, in response to temperature upshocks. J. Ind. Microbiol. Biotechnol. 28:333–
337.  
Delvigne, F., Destain, J., Thonart, P., 2006. A methodology for the design of scale-
down bioreactors by the use of mixing and circulation stochastic models. Biochem. 
Eng. J. 28:256–268.  
Desai, T. A., Rao, C. V., 2010. Regulation of Arabinose and Xylose Metabolism in 
Escherichia coli. Appl. Environ. Microbiol. 76:1524-1532.  
Dominguez, A. A., Lim, W. A., Qi, L. S., 2016. Beyond editing: repurposing CRISPR-
Cas9 for precision genome regulation and interrogation. Nature Rev. Mol. Cell. Biol. 
17:5-15. 
Drioli, E., Stankiewicz, A. I., Macedonio, F., 2011. Membrane engineering in process 
intensification-An overview. J. Memb. Sci. 380:1-8.  
Ecker, J., Raab, T., Harasek, M., 2012. Nanofiltration as key technology for the 
separation of LA and AA. J. Memb. Sci. 389:389–398.  
Eggeling, L., Oberle, S., Sahm, H., 1998. Improved L-lysine yield with 
Corynebacterium glutamicum: Use of dapA resulting in increased flux combined with 
growth limitation. Appl. Microbiol. Biotechnol. 49:24–30.  
Eggeling, L., Bott, M., 2005. Handbook of Corynebacterium glutamicum. CRC Press-
Taylor & Francis group. 
Elmar, H., Arno, P. B., Charles, L. C., 2007. Development of Sustainable Bioprocesses: 
Modeling and Assessment. John Wiley & Sons, Inc.  
Enfors, S.O., Jahic, M., Rozkov, A., Xu, B., Hecker, M., Jürgen, B., Krüger, E, 
Schweder, T., Hamer, G., O'Beirne, D., Noisommit-Rizzi, N., Reuss, M., Boone, L., 
Hewitt, C., McFarlane, C., Nienow, A., Kovacs, T., Trägårdh, C., Fuchs, L., Revstedt, 
J., Friberg, P.C., Hjertager, B., Blomsten, G., Skogman, H., Hjort, S., Hoeks, F., Lin, 
H.Y., Neubauer, P., van der Lans, R., Luyben, K., Vrabel, P., Manelius, A. 2001. 
Physiological responses to mixing in large scale bioreactors. J. Biotechnol. 85:175–185.  
Fleurence, J., 1999. Seaweed proteins: biochemical, nutritional aspects and potential 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 19 
uses. Trends Food Sci. Technol. 10(1):25–28.  
Garcia, N., Lopez Elias, J.A., Miranda, A., Martinez Porchas, M., Huerta, N., Garcia, 
A., 2012. Effect of salinity on growth and chemical composition of the diatom 
Thalassiosira weissflogii at three culture phases. Lat. Am. J. Aquat. Res. 40(2):435–
440.  
Gatenby, C.M., Orcutt, D.M., Kreeger, D. A., Parker, B.C., Jones, V. A., Neves, R.J., 
2003. Biochemical composition of three algal species proposed as food for captive 
freshwater mussels. J. Appl. Phycol. 15(1):1–11.  
Gnoth, S., Jenzsch, M., Simutis, R., Lübbert, A., 2007. Process analytical technology 
(PAT): batch to-batch-reproducibility of fermentation processes by robust process 
operational design and control. J. Biotechnol.132:180–186. 
Gordon, D. M., 2013. The ecology of Escherichia coli, in: Donnenberg, M. S. (Eds.), 
Escherichia coli. Elsevier Inc., pp. 3-20. 
Goto, M., Obuchi, R., Hirose, T., Sakaki, T., Shibata, M., 2004. Hydrothermal 
conversion of municipal organic waste into resources. Bioresour. Technol. 93:279-284. 
Graziani, G., Schiavo, S., Nicolai, M.A., Buono, S., Fogliano, V., Pinto, G., Pollio, A., 
2013. Microalgae as human food: chemical and nutritional characteristics of the thermo-
acidophilic microalga Galdieria sulphuraria. Food Funct. 144–152.  
Gröger, H., 2003. Catalytic Enantioselective Strecker Reaction and Analogous 
Syntheses. Chem. Rev. 103:2795-2827. 
Harada, K., 1963. Asymmetric Synthesis of α-Amino acids by the Strecker Synthesis. 
Nature. 200:1201.  
Hauer, B., Breuer, M., Ditrich, K., Habicher, T., Keßeler, M., Stürmer, R., Zelinski, T., 
2004. Industrial methods for the production of optically active intermediates. Angew. 
Chemie - Int. Ed. 43: 788–824.  
Hermann, T., 2003. Industrial production of amino acids by coryneform bacteria. J. 
Biotechnol. 104: 155–172.  
Hirasawa, T., Shimizu, H., 2016. Recent advances in amino acid production by 
microbial cells. Curr. Opin. Biotechnol. 42:133-146. 
Hsiao, H. Y., Walter, J. F., Anderson, D. M., Hamilton, B. K., 1988. Enzymatic 
production of amino acids. Biotechnology and Genetic Engineering Reviews 6: 179-
220. 
Ikeda, M., 2003. Amino acids production processes, in: Scheper, T., Faurie, R., 
Thommel, J. (Eds.), Microbial Production of L-Amino Acids. Springer Berlin 
Heidelberg, pp. 1–35. 
Ikeda, M., Katsumata, R., 1995. Tryptophan Production by Transport Mutants of 
Corynebacterium glutamicum. Biosci. Biotechnol. Biochem. 59:1600–1602.  
Ikeda, M., Nakagawa, S., 2003. The Corynebacterium glutamicum genome: features 
and impacts on biotechnological processes. Appl. Microbiol. Biotechnol. 62(2-3):99–
109. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 20 
Ikeda, M., Ohnishi, J., Hayashi, M., Mitsuhashi, S., 2006. A genome-based approach to 
create a minimally mutated Corynebacterium glutamicum strain for efficient L-lysine 
production. J. Ind. Microbiol. Biotechnol. 33:610–615.  
Ikeda, M., Takeno, S., 2013. Amino Acid Production by Corynebacterium glutamicum, 
in: Yukawa H., Inui M. (Eds.), Corynebacterium glutamicum. Springer Berlin 
Heidelberg, Berlin, pp.107-147. 
Inoue, M., Enomoto, S., 1982. Ammonolysis of trichloroethylene to glycine. Bull. 
Chem. Jpn. 55: 33-5. 
Ivanov, K., Stoimenova, A., Obreshkova, D., Saso, L., 2014. Biotechnology in the 
production of pharmaceutical industry ingredients: amino acids. Biotechnol. Biotechnol. 
Equip. 27(2):3620-3626.  
Junker, B., Lester, M., Brix, T., Wong, D., Nuechterlein, J., 2006. A next generation, 
pilot-scale continuous sterilization system for fermentation media. Bioprocess Biosyst. 
Eng. 28(6):351–378.  
Käß, F., Junne, S., Neubauer, P., Wiechert, W., Oldiges, M., 2014. Process 
inhomogeneity leads to rapid side product turnover in cultivation of Corynebacterium 
glutamicum. Microb. Cell Fact. 13:6. 
Kattan Readi, O. M., Rolevink, E., Nijmeijer, K., 2014. Mixed matrix membranes for 
process intensification in electrodialysis of amino acids. J. Chem. Technol. Biotechnol. 
89:425-435. 
Kelle, R., Hermann, T., Bathe, B., 2005. L-Lysine Production, in: Eggeling, L., Bott, 
M., 2005. Handbook of Corynebacterium glutamicum. CRC Press-Taylor & Francis 
group, pp. 465–488. 
Khamduang, M., Packdibamrung, K., Chutmanop, J., Chisti, Y., Srinophakun, P., 2009. 
Production of L-phenylalanine from glycerol by a recombinant Escherichia coli. J. Ind. 
Microbiol. Biotechnol. 36:1267–1274.  
Khan, N.S., Mishra, I.M., Singh, R.P., Prasad, B., 2005. Modeling the growth of 
Corynebacterium glutamicum under product inhibition in L-glutamic acid fermentation. 
Biochem. Eng. J. 25, 173–178. doi:10.1016/j.bej.2005.01.025 
Kim, S.K., 2013. Marine Proteins and Peptides: Biological Activities and Applications. 
John Wiley & Sons, Ltd.  
Kim, T-I., 2010. Beyond borders.Biotechnology Industry Report 2014.   
Klejdus, B., Lojkova, L., Kula, E., Buchta, I., Hrdlicka, P., Kuban, V., 2008. 
Supercritical fluid extraction of amino acids from birch (Betula pendula Roth) leaves 
and their liquid chromatographic determination with fluorimetric detection. J. Sep. Sci. 
31: 1363-1373. 
Kocabaş, P., Çalik, P., Özdamar, T.H., 2006. Fermentation characteristics of L-
tryptophan production by thermoacidophilic Bacillus acidocaldarius in a defined 
medium. Enzyme Microb. Technol. 39(5):1077–1088.  
Koma, D., Yamanaka, H., Moriyoshi, K., Ohmoto, T., Sakai, K., 2012. Production of 
aromatic compounds by metabolically engineered Escherichia coli with an expanded 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 21 
shikimate pathway. Appl. Environ. Microbiol. 78(17):6203–6216.  
Koyoma, Y., Ishii, T., Kawahara, Y., Koyoma, Y., Shimizu, E., Yoshioka, T., 1998. 
Method for producing L-glutamic acid by continuous fermentation. European patent 
application EP844308. 
Kuerová, Z., Tichá, M., 2009. The Shikimate Pathway: Aromatic Amino Acids and 
Phenylpropanoids, in: Dewick, P. M., Med. Nat. Prod. A Biosynthetic Approach. 3rd 
ed. John Wiley & Sons, Ltd. pp. 121–166. 
Kumagai, H., 2000. Microbial production of amino acids in Japan. Adv. Biochem. Eng. 
Biotechnol. 69:71–85.  
Kumagai, H., 2013. Amino acid production, in: DeLong, E. F., Stackebrandt, E., Lory, 
S., Thompson, F. (Eds.), The Prokaryotes. Springer-Verlag Berlin Heidelberg, Berlin, 
pp. 169-177. 
Kumar, M., Tripathi, B. P., Shahi, V. K., 2010.Electro-membrane process for the 
separation of amino acids by iso-electric focusing. J. Chem. Technol. Biotechnol. 85: 
648–657. 
Kumar, R., Vikramachakravarthi, D., Pal, P., 2014. Production and purification of 
glutamic acid: A critical review towards process intensification. Chem. Eng. Process. 
81:59–71.  
Kurihara, K., 2009. Glutamate : from discovery as a food flavor to role as a basic taste 
(umami). Am. J. Clin. Nutr. 90:719–722.  
Lara, A.R., Galindo, E., Ramírez, O.T., Palomares, L. A., 2006. Living with 
heterogeneities in bioreactors: understanding the effects of environmental gradients on 
cells. Mol. Biotechnol. 34:355–381.  
Lemoine, A., Maya Martίnez-Iturralde, N., Spann, R., Neubauer, P., Junne, S., 2015. 
Response of Corynebacterium glutamicum exposed to oscillating cultivation conditions 
in a two- and a novel three-compartment scale-down bioreactor. Biotechnol. Bioeng. 
112:1220-1231. 
Leuchtenberger, W., Huthmacher, K., Drauz, K., 2005. Biotechnological production of 
amino acids and derivatives: current status and prospects. Appl. Microbiol. Biotechnol. 
69(1):1–8. 
Liebl,W., 2005. Corynebacterium Taxonomy, in: Eggeling, L., Bott, M. (Eds.), 
Handbook of Corynebacterium glutamicum, Taylor & Francis, pp. 9-34.  
Longobardi, G. P., 1994. Fed-batch versus batch fermentation. Bioprocess Eng. 10: 
185-194. 
Lütke-Eversloh, T., Santos, C.N.S., Stephanopoulos, G., 2007. Perspectives of 
biotechnological production of L-tyrosine and its applications. Appl. Microbiol. 
Biotechnol. 77:751–762.  
Matassa, S., Verstraete, W., Pikaar, I., Boon, N., 2016. Autotrophic nitrogen 
assimilation and carbon capture for microbial protein production by a novel enrichment 
of hydrogen-oxidizing bacteria. Water Res. 101, 137–146. 
doi:10.1016/j.watres.2016.05.077 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 22 
Mänttäri, M., Van der Bruggen, B., Nyström, M., 2013. Nanofiltration, in: 
Ramaswarny, S., Huang, H. J., Ramarao, B. V. (Eds.), Separation and Purification 
technologies in Biorefineris, John Wiley and Sons, pp.233-258.  
März, U., 2009. World Markets for Fermentation Ingredients. Available from: 
http://www.bccresearch.com/market-research/food-and-beverage/fermentation-
ingredients-fod020c.html (accessed 09.02.17) 
Moritz, B., Striegel, K., De Graaf, A. A., Sahm, H., 2000. Kinetic properties of the 
glucose-6-phosphate and 6-phosphogluconate dehydrogenases from Corynebacterium 
glutamicum and their application for predicting pentose phosphate pathway flux in vivo. 
Eur. J. Biochem. 267:3442–3452.  
Nasseri, A.T., Rasoul-Amini, S., Morowvat, M. H., Ghasemi, Y., 2011. Single Cell 
Protein: Production and Process. Am. J. Food Technol. 6:1-13. 
Neubauer, P., Junne, S., 2010. Scale-down simulators for metabolic analysis of large-
scale bioprocesses. Curr. Opin. Biotechnol. 21(1):114–121. 
Noor, R., Islam, Z., Munshi, S. K., Rahman, F., 2013. Influence of Temperature on 
Escherichia coli Growth in Different Culture Media. 7:899-904. 
Ogata, Y., Inaishi, M., 1981. Preparation of DL-alanine by the reaction of (±)-2-
cholopropionic acid with aqueous ammonia under pressure. Bull. Chem. Soc. Jpn. 
54: 3605-3606. 
Park J. H., Lee, K. H., Kim, T.Y., Lee, S. Y., 2007. Metabolic engineering of 
Escherichia coli for the production of L-valine based on transcriptome analysis and in 
silico gene knockout simulation. Proc. Natl. Acad. Sci. U. S. A. 104: 7797-7802. 
Park, J.H., Lee, S.Y. 2010. Fermentative production of branched chain amino acids: a 
focus on metabolic engineering. Appl. Microbiol. Biotechnol. 85(3):491–506. 
Park, J.H., Oh, J.E., Lee, K.H., Kim, J.Y., Lee, S.Y., 2012. Rational design of 
Escherichia coli for L-isoleucine production. ACS Synth. Biol. 1(11):532–540. 
Patnaik, R., Zolandz, R.R., Green, D.A., Kraynie, D.F., 2008. L-tyrosine production by 
recombinant Escherichia coli: Fermentation optimization and recovery. Biotechnol. 
Bioeng. 99:741–752.  
Paul, B.D., Sbodio, J.I., Xu, R., Vandiver, M.S., Cha, J.Y., Snowman, A.M., Solomon, 
H. S., 2014. Cystathionine γ-lyase deficiency mediates neurodegeneration in 
Huntington’s disease. Nature. 509: 96-100. 
Pittard J., Camakaris H., Yang J., 2005. The TyrR regulon. Mol. Microbiol. 55: 16–26. 
Pollegioni, L., Servi, S., 2003. Unnatural amino acids methods and protocols. Humana 
Press.  
Pourali, O., Asghari, F.S.,Yoshida, H., 2009. Sub-critical water treatment of rice bran to 
produce valuable materials. Food Chem. 115:1-7. 
Ramakrishnan, V., Ghaly, A.E., Brooks M. S., Budge S. M.,2013. Enzymatic extraction 
of amino acids from fish waste for possible use as a substrate for production of 
jadomycin. Enz. Eng. 2:112. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 23 
Ramos Tercero, E. A., Sforza, E., Morandini, M., Bertucco, A., 2014. Cultivation of 
Chlorella protothecoides with urban wastewater in continuous photobioreactor: 
Biomass productivity and nutrient removal. Appl. Biochem. Biotechnol. 172(3):1470–
1485.  
Renneberg, R., 2008. High grade cysteine no longer has to be extracted from hair, in: 
Demain, A.L., (Eds.), Biotechnology for Beginners. Elsevier, p. 106.  
Renaud, S.M., Thinh, L.-V., Lambrinidis, G., Parry, D.L., 2002. Effect of temperature 
on growth, chemical composition and fatty acid composition of tropical Australian 
microalgae grown in batch cultures. Aquaculture. 211(1-4):195–214.  
Rittmann, D., Lindner, S.N., Wendisch, V.F., 2008. Engineering of a glycerol 
utilization pathway for amino acid production by Corynebacterium glutamicum. Appl. 
Environ. Microbiol. 74(20):6216–6222.  
Rodriguez, A., Martínez, J. A., Flores, N., Escalante, A., Gosset, G., Bolivar, F., 2014a. 
Engineering Escherichia coli to overproduce aromatic amino acids and derived 
compounds. Microb. Cell Fact. 13:126.  
Sabri, S., Nielsen, L. K., Vickers, C. E., 2013. Molecular Control of Sucrose utilization 
in Escherichia coli W, an Efficient Sucrose-Utilizing Strain. Appl. Environ. Microb. 
79:478-487. 
Sahm, H., Eggeling, L., de Graaf, A A., 2000. Pathway analysis and metabolic 
engineering in Corynebacterium glutamicum. Biol. Chem. 381:899–910.  
Sano, C., 2009. History of glutamate production. Am. J. Clin. Nutr. 90:728S-732S. 
Scheper, H., Lammers, F., 1994. Fermentation monitoring and process control. Curr. 
Opin. Biotechnol. 2:187-191. 
Schmidt, F. R., 2005, Optimization and scale up of industrial fermentation processes. 
Appl. Micorbiol. Biotchnol. 68:425-435. 
Sereewatthanawut, I., Prapintip, S., Watchiraruji, K., Goto, M., Sasaki, M., Shotipruk, 
A., 2008. Extraction of protein and amino acids from deoiled rice bran by subcritical 
water hydrolysis. Bioresour. Technol. 99:555–561.  
Shu, C.H., Liao, C.C., 2002. Optimization of L-phenylalanine production of 
Corynebacterium glutamicum under product feedback inhibition by elevated oxygen 
transfer rate. Biotechnol. Bioeng. 77:131–141.  
Singh, S., Gogoi, B.K., Bezbaruah, R.L., 2011. Racemic resolution of some DL-amino 
acids using Aspergillus fumigatus L-amino acid oxidase. Curr. Microbiol. 63:94–99.  
Sprenger, G.A., 1995. Genetics of pentose-phosphate pathway enzymes of Escherichia 
coli K-12. Arch. Microbiol. 164: 324–330. doi:10.1007/s002030050270 
Stincone, A., Prigione, A., Cramer, T., Wamelink, M.M.C., Campbell, K., Cheung, E., 
Olin-Sandoval, V., Grüning, N.M., Krüger, A., Tauqeer Alam, M., Keller, M.A., 
Breitenbach, M., Brindle, K.M., Rabinowitz, J.D., Ralser, M., 2015. The return of 
metabolism: Biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. 
90: 927–963. doi:10.1111/brv.12140 
Strecker, A., 1850. Ueber die künstliche Bildung der Milchsäure und einen neuen, dem 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 24 
Glycocoll homologen Körper. Justus Liebigs Ann. Chem. 75: 27–45. 
doi:10.1002/jlac.18500750103 
Suman, G., Nupur, M., Anuradha, S., Pradeep, B., 2015. Single Cell Protein Production: 
A Review. Int.J.Curr.Microbiol.App.Sci 4: 251–262. 
Takors, R., 2012. Scale-up of microbial processes: Impacts, tools and open questions. J. 
Biotechnol. 160(1-2):3–9.  
Tatarko M., Romeo T., 2001. Disruption of global regulatory gene to enhance 
central carbon flux into phenylalanine biosynthesis in Escherichia coli. Curr. 
Microbiol. 43: 26–32. 
Transparency Market Research. Commercial Amino Acids Market - Global Industry 
Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018. 2013.  
Ugimoto, M.S., 2010. Amino acids, production processes, in: Flickinger M. C. (Eds.), 
Encyclopedia of Bioprocess Technology. John Wiley & Sons, pp. 1–11.  
Utagawa, T., 2004. Production of arginine by fermentation. J. Nutr. 134(10):2854–
2857.  
Vaghari, H., Eskandari, M., Sobhani, V., Berenjian, A., Song, Y., Jafarizadeh-Malmiri, 
H., 2015. Process intensification for production and recovery of biological products. 
Am. J. Biochem. Biotechnol. 11: 37–43. doi:10.3844/ajbbsp.2015.37.43. 
Villadsen, J., Lidén, G., Nielsen, J., 2011. Bioreaction Engineering Principles, third ed. 
Springer, New York.  
Volker, F., 2006. Genetic Regulation of Corynebacterium glutamicum Metabolism. J. 
Microbiol. Biotechnol. 16:999–1009.  
Weiner, M., Albermann, C., Gottlieb, K., Sprenger, G. A., Weuster-Botz, D., 2014. 
Fed-batch production of L-phenylalanine from glycerol and ammonia with recombinant 
Escherichia coli. Biochem. Eng. J. 83:62–69. 
Weinert, D. J., 2009. Nutrition and muscle protein synthesis: a descriptive review. J. 
Can. Chiropr. Assoc. 53:186-193. 
Wendisch, V.F., Jorge, J.M., Pérez-García, F., Sgobba, E., 2016. Updates on industrial 
production of amino acids using Corynebacterium glutamicum. World J. Microbiol. 
Biotechnol. 32:105. 
Wittmann, C., Becker, J., 2007. The branched-chain amino acids, in: Amino Acid 
Biosynthesis. pp. 39–70. doi:10.1007/7171 
Wu, G., 2009. Amino acids: metabolism, functions, and nutrition. Amino Acids. 37:1. 
doi:10.1007/s00726-009-0269-0  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 25 
Wu, G., Bazer, F. W., Cudd, T. A., Meininger, C. J., Spencer, T. E., 2004a. Maternal 
Nutrition and Fetal Development. J. Nutr. 134:2169-2172. 
Wu, G., Fang, Y., Yang, S., Lupton, J. R., Turner, N. D., 2004b. Glutathione 
Metabolism and its Implications for Health. J. Nutr. 134:489-492. 
Xu, H., Miao, X., Wu, Q., 2006. High quality biodiesel production from a microalga 
Chlorella protothecoides by heterotrophic growth in fermenters. J. Biotechnol. 
126(4):499–507.  
Yakandawala N., Romeo T., Friesen A.D., Madhyastha S., 2008. Metabolic 
engineering of Escherichia coli to enhance phenylalanine production. Appl. 
Microbiol. Biotechnol. 78: 283–291. 
Yamane, H., Tomonaga, S., Suenaga, R., Denbow, D. M., Furuse, M., 2007. 
Intracerebroventricular injection of glutathione and its derivative induces sedative and 
hypnotic effects under acute stress in neonatal chicks. Neurosci. Lett. 418:87-91. 
Yi J., Draths K.M., Li K., Frost J.W., 2003. Altered glucose transport and shikimate 
pathway product yields in E. coli. Biotechnol. Prog. 19: 1450–1459.  
Yukawa, H., Inui, M., 2013. Corynebacterium glutamicum: Biology and Biotechnology, 
Springer.  
Zahoor, A., Lindner, S.N., Wendisch, V.F., 2012. Metabolic engineering of 
Corynebacterium glutamicum aimed at alternative carbon sources and new products. 
Comput. Struct. Biotechnol. J. 3 (4):1–11.  
Zhang, J., Zhang, S., Yang, X., Qiu, L., Gao, B., Chen, J., 2016. Reactive extraction of 
amino acids mixture in hydrolysate from cottonseed meal with di (2-ethylhexyl) 
phosphoric acid. J. Chem. Technol. Biotechnol. 91: 483–489. 
Zhao, G., Gong, G., Wang, P., Wang, L., 2014. Enzymatic synthesis of L-aspartic acid 
by Escherichia coli cultured with a cost-effective corn plasm medium. Ann. Microbiol. 
64:1615–1621.  
Zhao, Z.J., Zou, C., Zhu, Y.X., Dai, J., Chen, S., Wu, D., Wu, J., Chen, J., 2011. 
Development of L-tryptophan production strains by defined genetic modification in 
Escherichia coli. J. Ind. Microbiol. Biotechnol. 38:1921–1929.  
Zhou, L.B., Zeng, A.P., 2015a. Exploring lysine riboswitch for metabolic flux control 
and improvement of l-lysine synthesis in Corynebacterium glutamicum. ACS Synth. 
Biol. 4:729-734. 
Zhou, L.B., Zeng, A.P., 2015b. Engineering a lysine-ON riboswitch for metabolic 
control of lysine production in Corynebacterium glutamicum. ACS Synth. Biol. 4:1335-
1340. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 26 
Zuend, S.J., Coughlin, M.P., Lalonde, M.P., Jacobsen, E.N., 2009. Scaleable catalytic 
asymmetric Strecker syntheses of unnatural alpha-amino acids. Nature. 461(7266):968–
970.  
 
Figure captions 
Figure 1: Embden-Meyerhof-Parnas pathway. In the first step of the pathway glucose is 
phosphorylated to glucose-6-phosphate using ATP by means of the hexokinase enzyme. 
Glucose-6-phosphate is then isomerized to fructose-6-phosphate by means of a 
reversible reaction catalyzed by phosphoglucose isomerase (PGI). A phosphate group 
was added to fructose-6-phosphate to convert it in fructose-2,6-bisphosphate by means 
of the enzyme phosphofructokinase (PFK). Aldolase catalyses the transformation of 
fructose-2,6-bisphosphate into dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde-3-phosphate. Only glyceraldehyde-3-phosphate can be used in 
glycolysis so the enzyme triosephosphate isomerase (TIM) enables the transformation 
of DHPA into glyceraldehyde-3-phosphate. Glyceraldehyde-3-phosphate is converted to 
1,3-bisphosphoglycerate by means of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and the reduction of  NAD
+
 to NADPH. Phosphoglycerate kinase (PGK) 
catalyzes the formation of ATP to ADP and the formation of 3-phosphoglycerate using 
a phosphate group of 1,3-bisphosphoglycerate. The transformation of 3-
phosphoglycerate to 2-phosphoglycerate is catalyzed by phosphoglycerate mutase 
(PGAM). The dehydration of 2-phosphoglycerate to phosphoenolpyruvate is obtained 
by means of the enzyme enolase. The final step is the phosphorylation of  
phosphoenolpyruvate to a molecule of pyruvate by means of pyruvate kinase (PK).  
Figure 2: Tricarboxylic acid cycle scheme. The pyruvate deriving from the Embden-
Meyerhof-Parnas pathway is decarboxylated to acetyl-CoA, the starting point of the 
tricarboxylic acid cycle. The Tricarboxylic acid cycle is composed by eight enzymatic 
reactions. 1. conversion of acetyl-CoA to citrate through a condensation reaction 
catalyzed by citrate synthase (CS). 2. citrate is then dehydrated and subsequently 
hydrated to isocitrate by means of aconitase (ACN). 3. isocitrate is oxidated and 
carboxylated to 2-oxoglurate by the enzyme 2-oxoglutarate dehydrogenase complex 
(OGDHC). 4. 2-oxoglurate is decarboxylated to succinyl-CoA by means of succinyl-
CoA-synthetase (SCS). 5. succinyl-CoA is  phosphorylated to succinate by succinate: 
menaquinone oxidoreductase (SQO). 6. succinate is oxidated to fumarate by means of 
fumarase (Fum). 7. fumarate is hydrated to malate by the enzyme malate: quinone 
oxidoreductase (MQO). 8. malate is oxidated to oxaloacetate. 
Figure 3: L-lysine synthetic pathway in C. glutamicum. In the lysine synthetic pathway 
its precursor, oxaloacetate, is converted to aspartate by the addition of an amino-group 
taken from glutamate. The aspartate is then converted to L-4-aspartyl phosphate by 
phosphorylation by means of aspartate kinase (AK). A further conversion of L-4-
aspartyl phosphate to L-aspartate 4-semialdehyde was achieved by means of NADPH 
and the reaction was catalyzed by aspartate semialdehyde dehydrogenase (ASADH). 
Dihydrodipicolinate synthase (DHDPS) catalyzed the production of dehydrodipicolinate 
by reaction with pyruvate. Dehydrodipicolinate is further converted to L-piperidine 2,6-
dicarboxylate with the aid of the reducing agent NADPH and the enzyme 
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dihydrodipicolinate reductase (DHDPR). L-piperidine 2,6-dicarboxylate can be directly 
converted to  meso-2,6-diaminopimelate by addition of an amino-group by means of 
diamino pimelate dehydrogenase (DAPDH), or it can go through four successive 
reactions, involving tetrahydrodipicolinate succinylase (dapD), succinyl-amino 
ketopimelate transaminase (dapC), succinyl-amino pimelate succinylase (dapE) and 
diaminopimelate epimerase (dapF). The final step is the decarboxylation of meso-2,6-
diaminopimelate to lysine by menas of the enzyme diaminopimelate decarboxylase 
(DAPDC). 
Figure 4: PPP of E.coli. Two different phases are present in the PPP, namely oxidative 
and non oxidative branches. In the first step of the oxidative branch glucose is 
phosphorylated to glucose-6-phosphate by means of the hexokinase enzyme. Glucose 6-
phosphate dehydrogenase (G6PD) catalyzed the dehydrogenation of glucose-6-
phosphate to 6-phospho-D-glucono-1,5-lactone with the production of NADPH. 6-
phospho-D-glucono-1,5-lactone is hydrated to 6-phospho-D-gluconate by means of 6-
phosphogluconolactonase (PGLS) and finally  6-phospho-D-gluconate is converted to 
D-ribulose-5-phosphate through an oxidative decarboxylation reaction catalyzed by 6-
phosphogluconate dehydrogenase (6PGD). In the non oxidative branch, through several 
steps catalyzed by transketolase enzyme (TKT), D-ribulose-5-phosphate is converted to 
D-glyceraldehyde-3-phosphate and D-fructose-6-phosphate. 
Figure 5: Shikimate pathway. In the first step in the shikimate pathway an aldol-type 
condensation reaction takes place to combine the phosphoenolpyruvate and the D-
erythrose to give 3-deoxy-D-arabino-heptulosonic acid 7-phosphate (DAHP) by means 
of 3-Deoxy-D-arabino-heptulosonate-7-phosphate (DAHP synthase). The elimination of 
phosphoric acid from the DAHP to generate the 3-dehydroquinic acid represents the 
second step in the cycle, catalyzed by 3-dehydriquinate synthase (DHQ_synthase). 3-
dehydroquinic acid can then be reduced to quinic acid or dehydrated and reduced to 3-
dehydroshikimic acid by means of 3-dehydriquinate dehydratase (Dhquinase). 
Protocatechuic acid and gallic acid can be form by secondary reactions, involving 
dehydration and enolization or dehydrogenation and enolization respectively, from 3-
dehydroshikimic acid. Shikimic acid is formed by dehydration and reduction of 3-
dehydroshikimic acid by means of the enzyme shikimate dehydrogenase. Shikimic acid 
is converted to shikimate 3-phosphate by means of the shikimate kinase enzyme. 5-
enolpyruvylshikimate-3-phosphate (EPSP) is formed by reaction of shikimate 3-
phosphate with phosphoenol pyruvate, catalyzed by EPSP synthase. Finally chorismate 
is obtained by means of the enzyme chorismate synthase. 
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Table captions 
Table 1: Comparison among different amino acid production methods. Advantages and 
disadvantages of the different methods are presented. 
 
Table 2: Overview of yield obtained with different amino acids production methods.  
 
Table 3: Overview of metabolic engineering strategies to improve amino acid 
production using different microorganisms. 
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Table 1 
 
Process Principle Advantages Disadvantages 
Extraction from protein 
hydrolysates 
An amino acid can be 
separated from the 
others present in the 
protein-hydrolysates 
if its properties are 
different from the 
others 
 Large scale 
industrial 
production (Ikeda, 
2003) 
 Can use industrial 
by-products or 
waste (Hauer et 
al., 2004)  
 Common reagents 
such as 
hydrochloric acid 
and sodium 
hydroxide (Lütke-
Eversloh et al., 
2007) 
 Few kinds of amino 
acids (Ikeda, 2003) 
 Depend on the 
availability of 
natural protein rich 
resources (Hauer et 
al., 2004)  
 Possible protein 
degradation (Ikeda, 
2003) 
 By-products (Heuer 
et al., 2004) 
 Wastewater 
generation (Lütke-
Eversloh et al., 
2007; 
Sereewatthanawut 
et al., 2008) 
Chemical synthesis Amino acids obtained 
through a chemical 
reaction 
Produce achiral-
amino acids (Ivanov 
et al., 2014) 
 Production of 
racemic mixtures 
additional optical 
resolution step is 
necessary to obtain 
only the L-forms 
(Ikeda, 2003) 
 Price of the catalyst 
(Heuer et al., 2004) 
 Hazardous sources 
(Zuend et al., 2009) 
Enzymatic synthesis Application of 
proteases to peptide 
hydrolysis 
 Produce optically 
pure D and L- 
amino acids 
(Ikeda, 2003) 
 Very few amount 
of by-product 
(Ivanov et al., 
2014) 
 Simple process 
downstream 
(Ivanov et al., 
2014) 
 Price and instability 
of the enzyme 
(Ikeda, 2003) 
 Not favorable for 
production of L-
amino acids at 
industrial scale 
(Ikeda, 2003) 
 
Fermentation  Microorganisms 
convert the sugars 
present in a substrate 
into amino acids 
 Large scale 
industrial 
production of most 
of L- amino acids 
(Ivanov et al., 
2014) 
 Economic method 
 Sterility has to be 
ensured (Ugimoto, 
2010)  
 Energy required for 
oxygen transfer and 
mixing (Ugimoto, 
2010)  
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(Ikeda, 2003) 
 Production of L- 
amino acids form 
(Heuer et al., 
2004) 
 Mild conditions 
(Ugimoto, 2010)  
 Low plant 
maintenance costs 
(Ugimoto, 2010)  
 High operational 
costs (Ivanov et al., 
2014) 
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Table 2 
 
Method Source Reactiona or 
enzyme
b
 
Amino acid Yield 
(% w 
w
-1
) 
Reference 
Extraction Hair - L-cysteine 10 Renneberg, 2008 
Deoiled rice bran - Mixture  0.8 Sereewatthanawut 
et al. 2008 
Feather - L-leucine 
L-alanine 
L-serine 
0.7 
0.1 
0.2 
Cheng et al. 2008 
Chemical 
synthesis 
Trichloroethylene Ammonolysis
a
  L-glycine 40-70 Inoue and 
Enomoto 1982 
(±)-2-
chloropropionic 
acid  
Ammonolysis
a
 DL-alanine 78.0 Ogata and Inaishi 
1981 
Enzymatically 
catalyzed 
synthesis 
Fish waste Alcalase and 
Neutrase
b
  
L-alanine 
L-glycine 
L-
phenylalanine 
L-leucine 
L-serine 
7.6 
5.8 
4.2 
9 
4.3 
Ramakrishnan et 
al. 2013 
Phenylpyruvate 
 
Polyazetidine 
immobilized E. 
coli
b
 
L-
phenylalanine 
63 Hsiao et al. 1988 
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Table 3
1
 
 
Amino acid Strain 
Relevant 
characteristics 
Culture 
conditions  
(% wt v
-1
.) 
Titer
a
 (g L
-1
), 
or yield
b
 (gAA 
gsugar
-1
) 
Reference 
Corynebacterium glutamicum 
L-lysine 
MH20-
22B/pJC23 
AEC (AK
IS
) and 
Leu
-
, dapA on 
plasmid 
Glucose 
10% 
50
a
 Ikeda, 2003 
AGM5 hom and lysC 
mutations in the 
coding region 
Glucose 
50% 
About 90
a
 Ikeda et al., 
2006 
Lys-12 Replacement of tkt-
operon by the sod 
promoter 
Glucose 
10% 
120
a
 Becker et 
al., 2011 
L-glutamic 
acid 
F172-8 Reduced H
+
-ATPase 
activity 
Biotin 
limitation 
Glucose 
10% 
0.55
b
 Aoki et al., 
2005 
L-tryptophan KY9229 Defective in 
aromatic uptake 
system, introduction 
of plasmid pCA5 
which contained  a 
gene region involved 
in the uptake of 
aromatic amino 
acids 
Molasses 
(glucose) 
25% 
35
a
 Ikeda and 
Katsumata, 
1995 
Escherichia coli 
L-lysine BL21 (DE3) Contain the 
phenylalanine 
dehydrogenase gene 
of Acinetobacter 
lwoffii 
Glycerol 1% 0.58
b
 Khamduang 
et al., 2009 
L-
phenylalanine 
MG1655 
derivative 
Deletion of pheA, 
pheL and 
replacement of tyrA 
native chromosomal 
promoter with a 
strong trc promoter 
Glucose 3% 51
a
 Patnaik et 
al., 2008 
FUS4.11/pF81 
kan (W3110 
derivative) 
pykA gene deleted 
and pykF disrupted  
Glycerol and 
lactic acid 
16% 
0.15
b
 Weiner et 
al. 2014 
L- tryptophan FB-04/pSV03 
(W3110 
derivative) 
Deletion of trpR, 
tnaA, pheA and tyrA 
genes  
Glucose 
0.5% 
13.3
a
 Zhao et al. 
2011 
 
                                                        
1 AEC, S-(2-aminoethyl)-L-cysteine; AK, aspartate kinase; 
IS 
, insensitive to feedback regulation; dapA, 
dihydrodipicolinate synthase gene; hom, homoserine dehydrogenase gene; lysC, aspartate kinase gene; 
tkt, transketolase; sod, superoxide dismutase; pheA, bifunctional chorismate mutase/prephenate 
dehydratase; pheL, phe operon leader peptide; tyrA, chorismate mutase/prephenate dehydrogenase; pykA, 
pyruvate kinase II; pykF, pyruvate kinase I; trpR, tryptophan transcriptional repressor; tnaA, 
tryptophanase. 
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Figure 1 
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Figure 2 
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Figure 5 
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